AHF: Study on Impact of Expanding Access to Lenacapavir in Latin America to Be Presented in Mexico

Monday, October 20, 2025 | 9:30 – 11:00 a.m. (CDMX)
Virtual session

MEXICO CITY--(BUSINESS WIRE)--The AHF Global Public Health Institute for Latin America and the Caribbean, in collaboration with the National Institute of Public Health of Mexico (INSP), invites members of the press to a session presenting the report “Estimated Impact of Expanding Access to Lenacapavir in Latin America,” conducted by the INSP.

The study models the potential impact that broader access to lenacapavir—a long-acting injectable pre-exposure prophylaxis (PrEP) administered twice a year—could have in reducing new HIV infections in Argentina, Colombia, Mexico, Peru, and Venezuela.

The session will bring together public health experts, researchers, civil society representatives, and health authorities to discuss how to ensure equitable access to lenacapavir and analyze the challenges countries in the region face to integrate it into their HIV programs.

WHAT:	Session on Expanding Access to Lenacapavir in Latin America
WHEN:	Monday, October 20, 2025 9:30 – 11:00 a.m. (CDMX)
WHERE:	ZOOM LINK   Access Code: C1SPSEMI20 Webinar ID: 862 2875 8706
WHO:	Dr. Jorge Saavedra, Executive Director, AHF Global Public Health Institute Dr. Tonatiuh Barrientos Gutiérrez, Director of Research and Director, Center for Population Health Research, INSP Dr. Miguel Pedrola (Argentina), Scientific Director, AHF Latin America & the Caribbean Luz Marina Umbasia Bernal (Colombia), Public Citizen Álvaro Velarca, Chief of Staff to the Director General, IMSS
NEWS DESK NOTES	Q&A session at the end of the event.
MEDIA CONTACTS:	AHF Global Public Health Institute – Latin America & the Caribbean Dr. Ariel Terrón Director, AHF Global Public Health Institute for Latin America & the Caribbean WhatsApp: [phone] [e-mail] AHF Global Communications Denys Nazarov Director of Global Policy & Communications [phone] [e-mail]

The AHF Global Public Health Institute is an initiative of the AIDS Healthcare Foundation (AHF) created to advance global public health policy analysis and research, generating objective evidence to inform improvements in public health policy at the global, regional, national, and local levels, particularly in the field of infectious diseases. For more information about the AHF Global Public Health Institute, visit AHFinstitute.org.

AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to more than 2.6 million people in 50 countries worldwide in Africa, the Americas, the Asia/Pacific Region and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.